Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size ($ in 1000's) |
---|---|---|---|
AMBRX BIOPHARMA INC | 16,688,636 | UNCH | $237,646 |
AMAM | 16,688,636 | UNCH | $237,646 |
TG THERAPEUTICS INC | 4,046,598 | +4,046,598 | $69,116 |
TGTX | 4,046,598 | +4,046,598 | $69,116 |
MOONLAKE IMMUNOTHERAPEUTICS | 1,039,289 | +1,039,289 | $62,763 |
MLTX | 1,039,289 | +1,039,289 | $62,763 |
CYTOKINETICS INC | 600,000 | +600,000 | $50,094 |
CYTK | 600,000 | +600,000 | $50,094 |
KEROS THERAPEUTICS INC | 1,060,427 | +1,060,427 | $42,163 |
KROS | 1,060,427 | +1,060,427 | $42,163 |
VAXCYTE INC | 579,959 | +579,959 | $36,421 |
PCVX | 579,959 | +579,959 | $36,421 |
SPRINGWORKS THERAPEUTICS INC | 192,734 | +192,734 | $7,035 |
SWTX | 192,734 | +192,734 | $7,035 |
See Full List: All Stocks Held By Darwin Global Management Ltd.
— Including:
Biggest new positions
Biggest exits
Biggest increased positions
See Details: Top 10 Stocks Held By Darwin Global Management Ltd.
Size ($ in 1000's)
At 12/31/2023: $509,484 At 09/30/2023: $284,152 Darwin Global Management Ltd. holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Darwin Global Management Ltd. 13F filings. Link to 13F filings: SEC filings |